Synapse - American Society of Hematology

Results (5555)

Characterizing transcriptional and epigenetic signatures induced by FLT3-ITD activation

Meeting Abstract

Spitzer, B.; Guryanova, O. A.; Abdel-Wahab, O.; Kucine, N.; Adli, M.; Berman, J. N.; Meshinchi, S.; Bernstein, B.; Pelossof, R.; Leslie, C.; more...
Blood (2014)

Fulltext@MSK | Save

A systemic xenograft model of Waldenstrom's macroglobulinemia demonstrates the potent anti-tumor effect of second generation CD19 directed chimeric antigen receptor modified T cells in this disease

Meeting Abstract

Smith, E. L.; Palomba, M. L.; Park, J. H.; Brentjens, R. J.
Blood (2014)

Fulltext@MSK | Save

Subsequent hematopoietic stem cell transplantation in belinostat-treated patients with relapsed/refractory peripheral T-cell lymphoma (R/R PTCL)

Meeting Abstract

Shustov, A. R.; Al-Ali, H. K.; Wulf, G.; Hsu, P.; Choi, M. R.; Allen, L. F.; Visser, O. J.; Zachee, P.; Horwitz, S. M.
Blood (2014)

Fulltext@MSK | Save

Targeted therapy of B cell lymphoma with a direct inhibitor of the NF-kappa B subunit c-Rel

Meeting Abstract

Shono, Y.; Tuckett, A. Z.; Liou, H. C.; Ouk, S.; Doubrovina, E.; Doubrovin, M.; Derenzini, E.; Scallion, M. I.; Tsai, J. J.; Smith, O. M.; more...
Blood (2014)

Fulltext@MSK | Save

Treatment with antibiotics containing activity against obligate anaerobes worsens GVHD survival in mice and humans after allogeneic BMT

Meeting Abstract

Shono, Y.; Docampo, M. D.; Smith, O. M.; Gupta, J.; Lieberman, S. R.; Taur, Y.; Honda, K.; van den Brink, M. R. M.; Jenq, R. R.
Blood (2014)

Fulltext@MSK | Save

AG-221, a small molecule mutant IDH2 inhibitor, remodels the epigenetic state of IDH2-mutant cells and induces alterations in self-renewal/differentiation in IDH2-mutant AML model in vivo

Meeting Abstract

Shih, A. H.; Shank, K. R.; Meydan, C.; Intlekofer, A. M.; Ward, P.; Thompson, C. B.; Melnick, A. M.; Travins, J.; Straley, K.; Gliser, C.; more...
Blood (2014)

Fulltext@MSK | Save

Mutation profiling of therapy-related myeloid neoplasms using next-generation sequencing demonstrates distinct profiles from de novo disease

Meeting Abstract

Shih, A. H.; Rapaport, F.; Chung, S. S.; Dolezal, E. K.; Hobson, S.; Amato, M. K.; Park, C. Y.; Sekeres, M. A.; van den Brink, M. R. M.; Nimer, S.; more...
Blood (2014)

Fulltext@MSK | Save

Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium program

Meeting Abstract

Shen, Q.; Xu-Monette, Z. Y.; Manyam, G.; Visco, C.; Tzankov, A.; Cao, X.; Deng, L. J.; Montes-Moreno, S.; Dybkaer, K.; Chiu, A.; more...
Blood (2014)

Fulltext@MSK | Save

Second interim analysis of a phase 3 study of idelalisib (ZYDELIG®) plus rituximab (R) for relapsed chronic lymphocytic leukemia (CLL): Efficacy analysis in patient subpopulations with del(17p) and other adverse prognostic factors